# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-19-290451
Filing Date
2019-11-13
Accepted
2019-11-13 06:07:07
Documents
23
Period of Report
2019-11-13

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 6-K | d831563d6k.htm | 6-K | 48228
2 | GRAPHIC | g831563ceos10g1.jpg | GRAPHIC | 486597
3 | GRAPHIC | g831563ceos11g1.jpg | GRAPHIC | 284784
4 | GRAPHIC | g831563ceos12g1.jpg | GRAPHIC | 168212
5 | GRAPHIC | g831563ceos13g1.jpg | GRAPHIC | 48644
6 | GRAPHIC | g831563ceos14g1.jpg | GRAPHIC | 168729
7 | GRAPHIC | g831563ceos15g1.jpg | GRAPHIC | 151999
8 | GRAPHIC | g831563ceos16g1.jpg | GRAPHIC | 264814
9 | GRAPHIC | g831563ceos17g1.jpg | GRAPHIC | 285161
10 | GRAPHIC | g831563ceos18g1.jpg | GRAPHIC | 241772
11 | GRAPHIC | g831563ceos19g1.jpg | GRAPHIC | 335472
12 | GRAPHIC | g831563ceos1g1.jpg | GRAPHIC | 185733
13 | GRAPHIC | g831563ceos20g1.jpg | GRAPHIC | 277421
14 | GRAPHIC | g831563ceos21g1.jpg | GRAPHIC | 60487
15 | GRAPHIC | g831563ceos2g1.jpg | GRAPHIC | 48723
16 | GRAPHIC | g831563ceos3g1.jpg | GRAPHIC | 301392
17 | GRAPHIC | g831563ceos4g1.jpg | GRAPHIC | 315404
18 | GRAPHIC | g831563ceos5g1.jpg | GRAPHIC | 235634
19 | GRAPHIC | g831563ceos6g1.jpg | GRAPHIC | 243099
20 | GRAPHIC | g831563ceos7g1.jpg | GRAPHIC | 420037
21 | GRAPHIC | g831563ceos8g1.jpg | GRAPHIC | 315099
22 | GRAPHIC | g831563ceos9g1.jpg | GRAPHIC | 190026
23 | GRAPHIC | g831563g1111171418263.jpg | GRAPHIC | 8035
| Complete submission text file | 0001193125-19-290451.txt |  | 6989520

Mailing Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077
Business Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-29962 | Film No.: 191211601
SIC: 2834 Pharmaceutical Preparations